Today: 19 June 2026
Browse Category

NASDAQ:SNGX 27 May 2026

Soligenix Stock Nearly Doubles Before the Bell as Ebola Vaccine Hopes Put Tiny Biotech Back in Play

Soligenix Stock Nearly Doubles Before the Bell as Ebola Vaccine Hopes Put Tiny Biotech Back in Play

Soligenix Inc. shares jumped 94.6% to $1.00 in pre-market trading after linking its ThermoVax technology to the Bundibugyo Ebola outbreak in Congo and Uganda. The WHO declared the outbreak a Public Health Emergency of International Concern, with 105 confirmed cases and 10 deaths in DRC, and seven cases in Uganda. No FDA-approved vaccine exists for Bundibugyo virus. Soligenix has no product orders or revenue.
27 May 2026

Stock Market Today

  • Venture Global CFO Jonathan Thayer Sells 222,222 Shares Post Option Exercise
    June 18, 2026, 8:41 PM EDT. Venture Global CFO Jonathan W. Thayer executed options to acquire 222,222 Class A shares at $1.16 each, then sold them in open-market trades near $11 per share. This exercise-and-sell pattern converts option compensation into cash, reducing direct share ownership to zero, though Thayer retains 18.7 million options. The filing lacks a 10b5-1 plan disclosure, making the move a routine liquidity event rather than signaling insider confidence or concern. Investors view such open-market sales as more informative than tax-driven trades, but interpretation depends on wider portfolio and company context. This transaction underlines CFO's standard option monetization strategy without altering his exposure materially.

Latest articles

Kardigan pops in first Nasdaq trading after $400 million IPO

Kardigan pops in first Nasdaq trading after $400 million IPO

19 June 2026
Kardigan surged 37.5% above its $16 IPO price to close at $22 after raising $400 million in an upsized Nasdaq debut, signaling renewed investor appetite for large biotech IPOs as the company advances three late-stage cardiovascular drug candidates.
Go toTop